Archive for April, 2009

Prostate Health Information

Welcome! This Web site combines prostate cancer news, expert commentary, relevant clinical findings, updates on important prostate cancer research, and personal case histories to help you fully understand the important considerations in the diagnosis and treatment of disorders of the prostate. We hope you find it useful.

Preserving penis length after radical prostatectomy


Questioning hormone therapy as a primary cancer treatment for older men

Given the possible side effects of hormone therapy, such as bone loss, fractures, diabetes, and heart trouble, clinicians might want to think twice before prescribing hormone therapy as the primary cancer treatment for older men with early-stage disease.

What is prostatic intraepithelial neoplasia (PIN)?

No consensus exists about what type of medical follow-up is in order for this “precancerous” condition or whether to treat it. Marc B. Garnick, M.D., explains the condition and outlines your options.

Busy surgeons have better results

Study shows that patients have fewer complications when prostate surgery is done at a high-volume hospital by a surgeon who performs the operation regularly.

Experimental drug shows promise against prostate cancer

An experimental drug may halt the production of male hormones in the body, making it a promising treatment for prostate cancer patients whose tumors have not responded to other therapies. Preliminary studies showed shrinking tumors and drops in PSA levels.

Onions and garlic may ease BPH symptoms

Study shows that men with BPH typically eat less garlic and fewer servings of onions per week than those without BPH.

No difference between drug and placebo in treating chronic prostatitis

Many urologists prescribe alpha blockers to treat chronic prostatitis, but study shows that one such drug is ineffective in easing the condition.

Investigational vaccine aids patients with metastatic prostate cancer

A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by spurring their immune systems to fight the disease, according to a presentation by Iowa researchers at the American Urological Association’s annual meeting in May 2008. Enabling a patient’s immune system to attack cancer cells can improve quality of life and extend survival.

Data show drug’s benefit in preventing prostate cancer

Despite previous controversy, researchers report that finasteride may reduce overall disease risk and decrease rate of aggressive tumors.